We report a case of lung adenocarcinoma harboring a complex EML4-ALK (E13, A5, A20) fusion that coexisted with a BRAF mutation, as tested by DNA-NGS prior to treatment. This evidence concerns the gene BRAF and lung adenocarcinoma.